Importantly, SIRT1 activity is enhanced by small-molecule compounds; it may, therefore, be critically important to develop sirtuin activators tailored to cross the blood brain barrier to treat neurodegenerative diseases. This evidence concerns the gene SIRT1 and neurodegenerative disease.